Tech Company Financing Transactions
RoosterBio Funding Round
RoosterBio, based in Frederick, raised $15 million from Dynamk Capital and private investors.
Transaction Overview
Company Name
Announced On
8/7/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Dynamk Capital (Lead Investor) (Daniella Kranjac)
Proceeds Purpose
The investment will be used to expand and scale the RoosterBio team as its customer base continues to grow internationally, while bolstering research and development for their transformative next generation cell and gene therapy solutions.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5295 Westview Dr. 275
Frederick, MD 21703
USA
Frederick, MD 21703
USA
Phone
Website
Email Address
Overview
RoosterBio's founders have years of relevant technical, operational and regulatory experience and are considered leaders in the fields of Biomanufacturing and Regenerative Medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Margot Connor
VP - Bus. Development
Mary Fletcher
VP - Operations
Jacob Pattasseril
VP - Product Management
Jon Rowley
VP - Regulatory Affairs
Kathy Williams
Browse more venture capital transactions:
Prev: 8/7/2019: BlockFi venture capital transaction
Next: 8/7/2019: Cybereason venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs